Dynavax Technologies Corp live price charts and stock performance over time. The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. In depth view into DVAX (Dynavax Technologies) stock including the latest price, news, dividend history, earnings information and financials. View the latest Dynavax Technologies Corp. (DVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ. DVAX Stock Message Board for Investors. 6:04a Baidu stock price target raised to $450 from $180 at Susquehanna ... DVAX Profile. Why Dynavax Stock Is Crushing It Today. DVAX: Get the latest Dynavax Technologies stock price and detailed information including DVAX news, historical charts and realtime prices. Currency in USD, Trade prices are not sourced from all markets. Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference being held March 9-10, 2021. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Dynavax Technologies Corporation Common Stock (DVAX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest Dynavax Technologies Corporatio (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. * Average Estimates in Million (e.g. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. DVAX's price/sales ratio is 20.68; that's higher than the P/S ratio of 90.92% of US stocks. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA. In addition, it also granted nonstatutory stock options to purchase an aggregate of 74,300 shares of Dynavax common stock as inducements to four newly-hired employees in connection with commencement of their employment with the Company. DVAX has a greater average analyst price target than 34.22% of all US stocks. Real time Dynavax Technologies (DVAX) stock price quote, stock graph, news & analysis. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. Dynavax Technologies Corp. Stock Price, News and Company Updates. Stock analysis for Dynavax Technologies Corp (DVAX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. All rights reserved. Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that in connection with the commencement of Ms. MacDonald's employment with the Company as Senior Vice President and Chief Financial Officer on March 1, 2021, the Company granted her a non-statutory stock option to purchase 350,000 shares of Dynavax common stock. Revenue) or per share (e.g. Disclaimer | Get the latest stock price for Dynavax Technologies Corporation (DVAX:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. The CEO has said the First Quarter will produce more revenue than what the company has produced since 2004 . The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by 62.76% today. Federated Global Investment Management Corp. DVAX | Complete Dynavax Technologies Corp. stock news by MarketWatch. Dynavax Technologies Corp's number of analysts covering the stock is greater than 27.74% of all US stocks. Source: FactSet. (Biotech Stocks Hitting 52-week Highs Feb. 25). Find real-time DVAX - Dynavax Technologies Corp stock quotes, company profile, news and forecasts from CNN Business. risk, allowing investors to make better decisions and streamline their work ow. © 2021 Verizon Media. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by over 9% pre-market. Dynavax stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for DVAX in the last 3 months. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). Plus500. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) – a biopharmaceutical company focused on developing and commercializing novel vaccines – increased by over 9% pre-market as of 8:13 AM ET. Gainers The big gain came after the company announced better-than-expected fourth-quarter results after the market close on Thursday. Press Release reported on 03/01/21 that Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference 76.4% of retail CFD accounts lose money, Registration on or use of this site constitutes acceptance of our, Dynavax surges on prospects for COVID–19 vaccine adjuvant, 48 Stocks Moving In Friday's Mid-Day Session, Xtant Medical, Sensus Healthcare leads healthcare gainers; Tricida, Recro Pharma among major losers, The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida. Dynavax Technologies Corporation (NASDAQ:DVAX) went up by 3.25% from its latest closing price compared to the recent 1-year high of $12.44. The company’s stock price has collected 14.46% of gains in the last five trading sessions. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. Scaling The Peaks TradingView India. Stock quotes by finanzen.net. Dynavax is a huge buy from every historical perspective. Get Dynavax Technologies Corp (DVAX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. account day-to-day movements in market value compared to a company’s liability structure. Data provided by Edgar Online. balance sheet and inputs from the stock market. DVAX updated stock price target summary. Suite 900. Find market predictions, DVAX financials and market news. DVAX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 82.5% of US stocks. Subscribe to Premium to view Fair Value for DVAX. Commerce Policy | View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. Dynavax expects to make between $40 million and $60 million in the first quarter of this year from its CpG 1018 vaccine adjuvant. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s What happened. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Q When is the next Dynavax Technologies (DVAX) dividend? Made In NYC | View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. Yet the stock price sits at $8.50. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. A high-level overview of Dynavax Technologies Corporation (DVAX) stock. Shares of Dynavax (NASDAQ:DVAX) were skyrocketing 30.2% higher as of 3:47 p.m. EDT on Monday. Dow Jones, a News Corp company About WSJ. Company Profile. Dynavax Technologies Corp. 2100 Powell Street. View the real-time DVAX price chart on Robinhood and decide if you want to buy or sell commission-free. DVAX Stock Analysis Overview What this means: Dynavax Technologies (DVAX) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system. All rights reserved. Find market predictions, DVAX financials and market news. The biotech didn't report any new developments today. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Dynavax against related stocks people have also bought. Message Board Total Posts: 63 The stock price for . DVAX - Dynavax Technologies Corp Stock quote - CNNMoney.com Markets View real-time stock prices and stock quotes for a full financial overview. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) — a biopharmaceutical company focused on developing and commercializing vaccines — increased by 62.76% today as it went from a previous close of $6.31 to $10.27. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. Emeryville, California 94608 . DVAX Historical Data 1M 6M YTD 1Y 5Y MAX. DVAX Stock Summary. Dynavax Technologies (NASDAQ: DVAX) is $9.6 last updated Mon Feb 22 2021 21:00:02 GMT+0000 (Coordinated Universal Time). The big gain came after the company announced better-than-expected fourth-quarter results after the market close on Thursday. The stock price is undervalued: For a substantial part of 2020, Dynavax was one of the best stocks under $5 to buy in biotech, with a 52-week low of $1.80. The upside potential (average analyst target price relative to current price) of DVAX is higher than 86.4% of all US stocks. Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. The score provides a forward-looking, one-year measure of credit Dividend). Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. Updated daily, it takes into Stock quote and company snapshot for DYNAVAX TECHNOLOGIES CORP (DVAX), including profile, stock chart, recent news and events, analyst opinions, and research reports. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. This is why it happened. About Dynavax Dynavax is a commercial stage biopharmaceutical company developing and … This is why it happened. Here's a roundup of top developments in the biotech space over the last 24 hours: DOWNLOAD DATA Data is currently not available ... Get up to 10 years of daily historical stock prices & volumes. Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 48% to close at $5.58 on Friday. Check out our DVAX stock analysis, current DVAX quote, charts, and historical prices for Dynavax Technologies stock